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ABSTRACT 
Oocytes accumulate mRNAs in the form of maternal ribonucleoprotein (RNP) particles, 
the protein components of which determine the location and stability of individual mRNAs 
prior to translation. Scd6/Lsm14 proteins, typified by RAP55, function in a wide range of 
eukaryotes in repressing translation and relocating mRNPs to processing bodies and stress 
granules. In Xenopus laevis, the RAP55 orthologue xRAPA fulfills these functions. Here 
we describe the properties of a variant of xRAPA, xRAPB, which is a member of the 
Lsm14B group. xRAPB differs from xRAPA in various respects: it is expressed at high 
concentration earlier in oogenesis; it interacts specifically with the DDX6 helicase Xp54; it 
is detected in polysomes and stalled translation initiation complexes; its over-expression 
leads to selective binding to translatable mRNA species without evidence of translation 
repression or mRNA degradation. Since both Xp54 and xRAPA are repressors of 
translation, activation appears to be effected through targeting of xRAPB/Xp54. 
 
 
Key words: messenger ribonucleoprotein particles (mRNPs); Scd6/RAP55 proteins; 
LSM14B-A; Xp54/DDX6 helicase; post-transcripional control; Xenopus oogenesis. 
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1. Introduction 
 
Throughout its existence, mRNA is associated with a wide range of proteins that determine 
its history and fate: co-transcriptional processing, nucleocytoplasmic transport, cellular 
localization and ability to be translated, result from a succession of interactions with 
protein factors and microRNAs (Muller-McNicoll and Neugebauer, 2013). Although many 
RNA sequence- and structure-specific proteins have been identified, little is known of the 
extent of heterogeneity in protein composition across the range of mRNP particles.  In 
developing organisms, substantial amounts of mRNP are formed and stored until required 
for the synthesis of stage-specific proteins, whereas other mRNPs undergo immediate 
translation to establish the metabolic machinery (Lai and King, 2013).  Not only the timing 
of translation initiation is determined but also the cessation of translation and mRNA 
decay.  These and more subtle effects on the regulation of translation are incurred through 
the remodelling of mRNP particles. Key processes include: addition and removal of 
translation masking proteins, cytoplasmic regulation of poly(A) tail length, binding of 
translation initiation factors to the 5' cap structure, interaction of proteins bridging the 3' 
and 5' ends of the mRNA, mRNA localization, decapping and hydrolysis of the mRNA 
(Balagopal and Parker, 2009). 
    A paradigm for these various effects has been established from studies on oogenesis and 
early development of Xenopus laevis. Over a period of months, oocytes accumulate large 
numbers of non-translating, maternal mRNA molecules (>10
11
/ oocyte) that are stored to 
be mobilized to polysomes during later stages of oogenesis, oocyte maturation and, after 
fertilization, early embryogenesis. During their storage phase, most of these mRNAs have 
relatively short poly(A) tails (10-30 residues) at their 3' termini (Cabada et al., 1977). 
Several abundant proteins are found to be associated with these maternal mRNAs to form 
large RNA-protein complexes which mostly sediment at 30-80 S and have a buoyant 
density in CsCl of 1.36 g.cm
-3
 (equivalent to a protein:RNA mass ratio of 4:1).  
    The four most abundant proteins have apparent (electrophoresis) molecular masses 
between 50-60 kDa (Darnbrough and Ford, 1981): the two slowest migrating were 
identified as cold-shock domain Y-box proteins, FRGY2a/b (YB2: Deschamps et al., 1992; 
Murray et al.,1992) and the next as the DEAD-box RNA helicase Xp54/Dhh1 (Ladomery 
et al., 1997). The fourth protein, of 52 kDa, described in this report as xRAPB, is identified 
as a variant of RAP55 which is expressed in a wide range of organisms (Marnef et al., 
2009). RAP55 was first identified as an RNA-associated protein expressed in oocytes of 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 4 
the amphibian Pleurodeles waltl (Lieb et al. 1998). Its orthologue is also expressed in 
Xenopus oocytes and is here referred to as xRAPA. Both xRAPA and xRAPB, belong to 
the Scd6/Lsm14 family (Anantharaman and Aravind, 2004), characterized by a 
multidomain organization consisting of a conserved N-terminal Lsm domain and varied 
central and C-terminal regions defined by an FDF domain and RGG repeats (Albrecht and 
Lengauer, 2004). In this report we examine to what extent structural differences between 
xRAPA and xRAPB are reflected in differences in function.   
    RAP55/xRAPA has been shown to act as a translation repressor (Tanaka et al., 2006), as 
have the core mRNP proteins, YB2a/b (Kick et al.,1987: Matsumoto et al., 1996; Yurkova 
and Murray, 1997; Sommerville, 1999) and Xp54 (Minshall and Standart, 2004: Minshall 
et al., 2009), along with other mRNP proteins: CPEB (Minshall et al., 2007), 4-ET 
(Minshall et al., 2007) and P100/Pat1 (Marnef et al., 2010: Nakamura et al., 2010).  
However, other proteins, involved in mRNP trafficking and translation activation during 
oogenesis, have yet to be identified. Here we describe several features of xRAPB, which 
distinguish it from xRAPA, specifically in having a key role in the regulation of mRNA 
metabolism during the early stages of oocyte development. 
 
2. Materials and methods  
2.1 Sequencing and cloning 
    Sequence information for Xenopus laevis xRAPA was obtained originally from EST 
clones BG408666 and BG486665 (European Bioinformatics Institute: www.ebi.ac.uk) 
which showed 74% protein identity with RAP55 of Pleurodeles waltii (UNIPROT 
Q9YH12; www.uniprot.org ; Lieb et al., 1998) and were known to be expressed in oocytes 
of X. laevis. A complete coding sequence was constructed from PCR reactions and later 
found to be identical at the protein level to that of IMAGE clone 3405473 (I.M.A.G.E 
Consortium: www.imageconsortium.org). xRAPB was initially detected by peptide 
sequencing of an mRNP protein of 52 kDa isolated from stage I oocytes of X. laevis: one 
of the peptide sequences, M/VEQAV, did not occur in either RAP55 or xRAPA, but was 
later detected in a human clone (UNIPROT Q9BX40) which showed 45% identity with 
RAP55. X. laevis EST clones BI444610 and BG731378 were used to generate more 
extensive and overlapping sequences which were found to form a complete 5’ insert in 
IMAGE clone 3473035 and a complete 3’ insert in IMAGE clone 4674033, with a 299 bp 
overlap between them. 
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2.2 Expression vectors 
    PCR copies from cDNA clones encoding complete sequences of xRAPA and xRAPB 
were inserted into the pCS2*mt-SGP vector between the unique Eco RI site immediately 
downstream of the 6-times myc epitope  and the Xba I site immediately upstream of the in-
frame GFP sequence as described previously (Smillie and Sommerville, 2002). Stop 
codons were retained, or inserted, in a second set of vectors to generate transcripts lacking 
part or all of the GFP sequence. The pCGT vector expressing the complete sequences of 
Xp54 following a leader sequence encoding a T-epitope has been described (Smillie and 
Sommerville, 2002). All in vivo expression was driven from the CMV promoter. For in 
vitro expression, proteins were generated using the TNT Quick Coupled 
Transcription/Translation System (Promega, Madison, WI) according to the supplier’s 
instructions. Briefly, 0.5-2 g of plasmid DNA was used in combination with 20 Ci of 
[
35
S]-methionine (Redivue >1000 Ci/mmole; Amersham Biotech. GE Healthcare) and 
either T7 or SP6 RNA polymerase (Promega). After incubation at 30
o
C for 90 min., the 
reactions were filtered through Sephadex G-50 (GE Healthcare) by centifugation in micro-
pipette tips to separate the products from unincorporated radioactivity and small 
molecules. The integrity of radiolabelled products was checked by SDS-
PAGE/autoradiography. Quantitation of incorporation was calculated by sampling aliquots 
in duplicate on to GF/A glass fibre filters (Whatman, GE Healthcare), with and without 
TCA precipitation and followed by scintillation counting according to supplier’s 
instructions (Promega). 
2.3 Morpholinos 
Antisense morpholinos (Gene Tools, Philomath, OR) were directed against RNA 
sequences adjacent to translation start site (bold, where included): 
Xp54 mRNA     3’TACTCGTGGCGGTCTTGTCTCTTGG  5’ 
YB2 mRNA   3’CCTCGTACTCACTCCGCCTTCGGGC  5’ 
xRAPB mRNA  3’GGTATCAGGTTTCTGCTCGTAGTAC  5’ 
xRAPA mRNA  3’GTAGGTAGGCCCTCTATCCTACTCG  5’ 
pCS transcripts  3’GTTCGATGAACAAGAAAAACGACCT  5’ 
pCTG transcripts  3’TACCGAAGATCCTACCGTAGCTACT  5’   
Control      3’CCTCTTACCTCAGTTACAATTTATA  5’ 
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All injected antisense morpholinos showed specific down-regulation of both endogenous 
and recombinant forms of the target proteins. No deleterious effect on oocytes were 
observed. 
2.4 Oocyte isolation and extraction 
    Ovary was excised from immature X. laevis and oocytes were released and maintained 
in OR-2 medium and sorted into individual stages as described in detail (Sommerville, 
2010). Pools of ~1000, 400, 100 and 40 oocytes, of stages I, II, III and IV were 
homogenized in HB: 0.1 M NaCl; 2 mM MgCl2; 2 mM dithiothreitol, 20mM Tris-HCl, pH 
7.5. Yolk and lipid were extracted with 1,1,2-trichlorotrifluoroethane (Evans and Kay, 
1991). After centrifugation at 10,000 rpm for 15 min at 0
o
C in a Sorvall SS-34 rotor, the 
clarified supernatant (SN10) was carefully removed. The extracts were maintained at <2
o
C 
throughout and adjusted to 40 units/ l RNasin (Promega) and where appropriate 5 mM 
EDTA (Sigma). Poly(A
+
) RNP was bound to and eluted from oligo(dT) cellulose (Type 7; 
Pharmacia, GE Healthcare) as described previously (Ladomery et al., 1997). Typical 
recovery of poly(A
+
) RNP from early stage oocytes was 250-350 g/ml eluate. 
2.4 Primary antibodies 
    Poly(A)
+
RNP from early (stage I) oocytes was separated into a heat stable supernatant 
containing YB2a/b (Deschamps et al., 1992) and a heat-labile precipitate containing 
principally Xp54 and xRAPB. Antibodies were raised against the renatured proteins from 
these two fractions. Rabbits producing anti-YB2 generally gave equal reactivity to the a 
and b forms. Rabbits producing antibodies to the heat-labile proteins gave variable 
immuno-reactivities, either against Xp54 or xRAPB. Antibodies specific for Xp54 and p52 
(xRAPB) were raised against gel-isolated proteins which were renatured by staged dilution 
from 8M urea into HB (Ladomery et al., 1997; Sommerville and Ladomery, 1996). Rabbit 
anti-ERK2 was obtained from Santa Cruz Biotech. (Santa Cruz, CA) rabbit anti-phospho-
MAP kinase from Cell Signalling (Danvers, MA). Rabbit anti-CPEB was kindly supplied 
by Laura Hake. Mouse monoclonal antibodies to the c-myc epitope (clone 9E10, Sigma-
Aldrich, St Louis, MO) and the bacteriophage T7 epitope (Novagen, Merck, Darmstadt) 
were used as recommended. 
2.6 Oocyte injection and radiolabelling  
    Stage IV oocytes from albino females were randomly distributed into four sets of 40-50 
oocytes and each set was colour-coded using vital stains as described (Sommerville, 2010). 
The different sets were used for injection of different expression vectors or morpholinos or 
as controls. For over-expression studies, 10 nl aliquots containing ~10 pg of purified 
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plasmid DNA were injected into the visible nucleus of colour-coded albino oocytes. 
Alternatively,  RNA transcribed with T3 or T7 polymerase (MessageMachine, Ambion, 
Waltham, MA) from 
Antisense probes were synthesized by the same method but labeled with 
32
[P]-CTP (0.1 
mCi/ml at >1000 Ci/mmole; Amersham). For knock-down expression, antisense or control 
morpholinos (5 ng in 20 nl aliquots) were injected into the cytoplasm. After injection the 
oocytes were pooled and incubated together in OR-2 at room temperature (20-22 
o
C) for 
periods of 6 to 36 h. For metabolic labelling of proteins, sets of 25 colour-coded oocytes 
from each injection treatment were pooled and labelled by addition of 30 l of 
[
35
S]methionine (0.1 mCi/ml at >1000 Ci/mmole; Amersham) to a total volume of 3 ml of 
OR2 in 30 mm diameter plastic dishes. At each time point, 5 oocytes of each colour were 
removed with a minimum of liquid and rinsed twice in 2 ml of OR2 before transfer to a 0.5 
ml centrifuge tube and frozen on dry ice. Quantitation of [
35
S]methionine 
incorporation/protein synthesis was carried out as described (Keiper and Rhodes, 1997).  
2.7 Immunoblotting 
    Proteins, equivalent to one oocyte, were separated by SDS-PAGE, transferred to 
nitrocellulose (0.45 micron, Pierce Biotech. Thermo Fisher) and immunoblotted as 
described previously (Ryan et al., 1999). Primary antisera or IgG were used at 1:5,000 or 
1:10,000, secondary antibodies were goat-anti-rabbit or goat-anti-mouse IgG conjugated to 
IR Dye 800CW (Li-COR, Odyssey Biosciences, Lincoln, NE) and were all used at 
1:40,000. Fluorescent bands were recorded using an Odyssey (Li-COR, Clx) infrared 
imaging system. All immunoblots shown are representative of those obtained from at least 
two experiments.  
2.8 Immunostaining 
    Xenopus laevis ovary was fixed in 2% trichloroacetic acid, dehydrated, embedded in 
wax and sectioned on to glass slides. Dewaxed sections were rinsed with PBST, incubated 
for 1 hour at 20oC with anti-p54 diluted 1:200 in 10% FCS/PBST, rinsed five times in 
PBST for 10 min, then incubated with FITC-conjugated anti-rabbit IgG (Chemicon) 
diluted 1:200 in 10% FCS/PBST. After rinsing in PBST a further five times, the sections 
were mounted in 20% glycerol / PBST and viewed using an Olympus BX51 fluorescence 
microscope fitted with an SIS View Firewire CC-12 digital camera (Olympus Soft 
Imaging, 48149 Munster, Germany).  
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2.9 Immunoprecipitation 
    Antibodies were linked to ProSep-vA beads (Millipore, Watford, UK) and proteins or 
mRNP bound from HB containing 0.05% NP-40 (Sigma) and released as described 
previously (Ryan et al., 1999).  
2.10 UV crosslinking 
   Samples of poly(A)
+
RNP (25-35 g in 100 l HB) were placed in a silicone-treated glass 
depression tray seated on ice and irradiated with 254-nm light at 6,000 W.cm-2 for 5 min 
to establish protein-RNA crosslinks or 30 min to produce (more extensive) protein-protein 
crosslinks. Half of irradiated samples were treated with 1 mg/ml ribonuclease A at 37
o
C 
for 30 min to resolve close protein-protein association. 
2.11 Rate sedimentation analysis 
    Clarified oocyte extracts and poly(A
+
) fractions were layered on 10-25% glycerol 
gradients made up in: 0.1 M NaCl; 2 mM MgCl2; 2 mM dithiothreitol; 20 mM Tris-HCl, 
pH 7.5 plus 0.05% NP-40, 40 units/ l RNasin, with and without 50 g/ml cycloheximide. 
For ribosome dissociation, MgCl2 was  replaced with 5 mM EDTA. After centrifugation at 
36,000 rpm in a 6 x 5 ml swing-out rotor (Beckman SW50Ti) at 0
o
C for 2-3 hours, the tube 
contents were fractionated. Fractions were analysed for proteins by immunoblotting. 
Sedimentation rates were calculated using 80S ribosomes and 60S and 40S ribosomal 
subunits run in parallel gradients and scanned through a flow cell measuring absorbance at 
254 nm. 
2.12 Density gradient centrifugation 
   Unfixed poly(A)
+
RNP samples (50-100 l) were layered on preformed gradients of 6-
48% Cs2SO4 in 0.1% NP40 (Sigma) and 50 mM sodium phosphate, pH 7.0. After 
centrifugation at 35,000 rpm for 16 h at 18
o
C in a Beckman SW50Ti rotor, the tube 
contents were fractionated. Density values were obtained by refractometry. Each fraction 
was diluted with 3 vol. dH2O, then RNP and proteins were ethanol precipitated, for protein 
extraction with addition of 10 g of cytochrome C and for RNA extraction with 10 g of 
yeast tRNA as carriers. Proteins were recovered from precipitatated fractions by standard 
preparation procedure for SDS-PAGE. RNA was recovered by SDS-protease treatment and 
standard phenol extraction. Unfixed poly(A)
+
RNP was also separated on preformed CsCl 
gradients, formed and analysed as above. 
     
2.13 RNA extraction, hybridization and RT-PCR 
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    RNA was isolated extracts of 25 oocytes or acetone- or ethanol-precipitated gradient 
fractions or from immunoprecipitates raised in 250 g HB plus 40 units/ l RNasin and 
from their supernatants, by addition of SDS to 1% followed by extractions with equal 
volumes of phenol-chloroform-isoamyl alcohol then chloform-isoamyl alcohol. 1/10
th
 
volume of 5M sodium acetate and 20 g transfer RNA (Sigma) were added to the extracts 
and RNA was ethanol precipitated. Dried pellets were raised in RNase-free H2O. RNA for 
hybridization analysis was either separated by gel electophoresis and transferred to nylon 
membranes or applied directly to the membranes using a Hybri-Slot Manifold (BRL, 
Bethesda) and hybridized with 
32
[P]-CTP labelled antisense probes essentially as described 
(Sheets et al., 2010). RNA as a template for two-stage RT-PCR was used with random 
hexamers in the ImProm-II
TM
 Reverse Transcription System (Promega) to generate cDNA 
followed by amplification with GoTaq
TM
 Master Mix (Promega) as specified by the 
manufacturer. Gene-specific primer pairs were used to generate products of 300-400 bp 
after 32 cycles. Products were analysed by electrophoresis on agarose gels as described 
(Huber and Zhao, 2010). 
Gene specific primer pairs: 
Nuclear actin (F): 5’CTCACCCTGAAGTATCCCATTG; (R): 5’GAAGCAGCTGTTGCCATTT  
tubulin (F): 5’CCCAACAACGTTAAGACCG; (R): 5’CCTCCTCTTCCCCTTCCT 
Cyclin B1 (F): 5”CTTTGGCTGGAAAGAGGGTTG; (R): 5’CTGACTGCTTGTGCATCCTCA 
D7 (F): 5’CCCTAAACAGGAGCTTGATCTG; (R): 5’CTGCACCATGGGTTTGTATTTG 
EF1 (F): 5’GGAGAATTTGAGGCTGGTATCT; (R) 5’GAGTCGTAGAGGCTTGTTAGTG 
HDAC (F): 5”CGGTTACGGGATGGGATTGAC; (R): 5’GTTGGATGGGCTGATGTGGAAG 
H1M (F): 5’CTGAGGGAGGCAACAAGGAAAAT; (R): 5’CTGCTCTGCATTTGGGTCTAC  
Mos (F): 5’GTGGCGCTGAAGAAGGTAAA; (R): 5’ATAGGCCACTACCGCATAGA 
Nanos1 (F): 5’CTGCAGCCTCAGAGAGAAGG; (R): 5’CCACACAAAGGGCAAGTGTA 
rp-L14 (F): 5’GTCGTACCAACTCCAGTTTCA; (R): 5’GTAGACTTCACGGGCCTTAC 
Vg1 (F): 5’CCATACCCGCTGACAGAAATA; (R): 5’CAGCTAACAGTCAAGGCAAATC 
Xcat2 (F): 5’GCTTTGACTCATGGAGCGAC; (R): 5’GCCGAGTGAGACATCAGTGT 
YB1 (F): 5’CAGTGTGGGAGATGGTGAAC; (R): 5’GAACTGGAGCATTGGAGTATTG  
 
3. Results 
3.1 Identification and expression of xRAPB 
    The original guinea pig antibody raised against recombinant RAP55 recognized three 
proteins in oocyte extracts from Pleurodeles waltl with apparent masses of 140, 68 and 56 
kDa, but only one protein from Xenopus laevis with a mass of 52 kDa (Lieb et al., 1998).  
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The 68 kDa protein was named RNA-associated protein 55 (the predicted mass of the 
sequenced clone being 55 kDa). The rabbit antibody raised against a 52 kDa protein 
isolated from Xenopus mRNP (Sommerville and Ladomery 1996) recognizes only the 52 
kDa Xenopus protein and the 56 kDa protein from Pleurodeles (Fig. 1A). Subsequent 
cDNA cloning, based on peptide analysis of the 52 kDa protein, eventually identified it as 
a shorter variant of RAP55, one which we named RapB/xRAPB (Weston and 
Sommerville, 2006; Marnef et al., 2009). The relationships between these proteins, 
including a form identical to xRAPB but with a single internal deletion (xRAP42; Arthur et 
al., 2009), are indicated (Fig. 1B).  
    Immunoblotting of extracts from developing oocytes using anti-p52/anti-xRAPB shows 
highest reactivity with early stages (I-II), with decreasing signal as oogenesis proceeds 
(Fig. 1C, top panel). Quantitation of the encoding mRNA/oocyte mass by RT-PCR reveals 
a similar pattern (Fig. 1C, bottom panel). However, on a per oocyte basis, the amount of 
xRAPB-encoding mRNA increases through oogenesis, indicating that expression of 
xRAPB, itself, is subject to translational control.  
    Immunostaining of ovary sections with anti-xRAPB reflects the immunoblotting results, 
with reaction steadily decreasing from early stage to be low in concentration by late stage 
(Fig. 1D). It is also apparent that the cognate protein is almost exclusively cytoplasmic, as 
has been shown for xRAPA (Tanaka et al., 2006).  
    Immunoblotting of oocyte fractions bound or unbound by oligo(dT)-cellulose shows that 
the protein detected by anti-xRAPB is bound to an extent similar to bona fide mRNP 
components, such as Xp54, YB2 and CPEB (Fig. 1E). Binding efficiency is similar in the 
presence of either Mg
2+ 
or EDTA, conditions which may influence intermolecular 
associations.  Xp54, YB2 and xRAPB continue to be present in the poly(A)
+
 fractions after 
progesterone-induced maturation, but at lower levels. Immunoreaction with anti-ERK2 is 
shown as a non-mRNP control and with anti-pMAPK as an oocyte maturation marker. 
    All indications are that xRAPB is an integral component of mRNP particles, particularly 
of a major population present in early oocytes. That xRAPB is a stably-bound component 
of these particles can be shown by equilibrium gradient centrifugation of unfixed poly(A)
+
 
RNP through high salt (15-40% Cs2SO4). Immunoblotting of gradient fractions with a 
mixture of antibodies to recognize the major mRNP proteins shows that xRAPB together 
with Xp54 remain bound to RNA (at a buoyant density of 1.44 g.cm
-3
) after much of the 
YB2 has been stripped off and recovered at around 1.22 g.cm
-3
 (Fig.1F). That the density 
peak represents the core of mRNP particles is demonstrated by extraction of RNA from the 
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gradient fractions and hybridization with labelled probes directed against a range of early-
expressed mRNAs, panels of two of which, nucleolin and histone deacetylase (HDACm) 
are shown (Fig. 1F). Thus the vast majority of hybridization signal corresponds to the 
position of the xRAPB immunostaining signal. For comparison, particles containing all of 
the major mRNP proteins can be obtained within a single density peak at around 1.39 
g.cm
-3
 on banding in CsCl gradients (Fig. 1F). This density in CsCl corresponds to a 
protein:RNA ratio approaching the value of 4:1 which is normally quoted for intact mRNP 
(Cummings and Sommerville, 1988). The differential removal of YB2, especially of 
YB2b, from mRNP in moderate salt conditions (1 M NaCl) has already been noted 
(Ladomery and Sommerville, 1994) and may help explain better retention of YB2 in CsCl 
than in Cs2SO4. 
 
3.2 Comparison of interactions of xRAPA and xRAPB with Xp54  
    Previous results have indicated a direct interaction of xRAPB with Xp54 helicase, an 
interaction that is not evidenced in early-stage oocytes with xRAPA (Minshall et al. 2007). 
Here we extend these observations by examining protein-protein interactions that occur 
using in vitro synthesised xRAPA, xRAPB and Xp54 (Fig. 2A) and compare the results 
with those obtained through crosslinking of proteins within native RNP particles. 
    Interaction of xRAPB with Xp54 can be shown by reciprocal immunoprecipitation from 
combinations of the in vitro-synthesized proteins. Incubation of xRAPB with Xp54 and 
xRAPA with Xp54 was followed by binding and elution from immobilized anti-Xp54 and 
anti-xRAPB. Autoradiographs show that anti-Xp54 co-precipitates xRAPB much more 
effectively than xRAPA (Fig. 2B, top) and that anti-xRAPB co-precipitates Xp54 with 
xRAPB but much less with xRAPA (Fig. 2B, bottom).  
    That xRAPB and p54 make close contacts in vivo can be shown by u.v.-crosslinking of 
native mRNP particles from early-stages (Fig. 2C). Here, both xRAPB and Xp54 are found 
in complexes with identical mobilities on SDS-PAGE at about 110 kDa, even on using 
heat-treated pellets which lack YB2 and mRNA and are reacted simultaneously with anti-
xRAPB and anti-Xp54. This Mr value corresponds with the interpretation of the formation 
of heterodimers. These complexes are not affected by ribonuclease treatment after 
irradiation. In comparison, other mRNP components (eg.YB2a/b) form differently-
migrating complexes (right panel). Larger complexes running at the top of the gel and 
detected with anti-Xp54 and anti-YB2, but not with anti-xRAPB, are disaggregated on 
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ribonuclease treatment. This observation suggests that xRAPB, unlike Xp54  and YB2, 
may have no direct RNA-binding activity.  
    These results indicate that, during early oogenesis, xRAPB is a natural partner protein 
for the RNA helicase Xp54, perhaps in selecting mRNAs for early translation. 
 
3.3 xRAPB expression complements Xp54 expression in the formation of mRP particles 
    In order to study the interaction of xRAPB and Xp54 in the assembly of mRNP 
particles, recombinant forms of the proteins were expressed in vivo after injection into 
mid-stage, oocytes. T7-tagged Xp54 and myc -tagged xRAPB, or myc -tagged xRAPA, 
were co-expressed from CMV-driven vectors injected directly into oocyte nuclei. This 
approach has the advantage of accessing the complete, natural pathway of gene expression 
and therefore is more likely to produce correctly located and functioning proteins 
(Braddock et al., 1994; Matsumoto et al., 1998). The compositions of the three 
recombinant proteins, showing the location of their functional domains, are represented in 
Fig. 3A.  
    The relative rates of synthesis of the epitope-tagged proteins were compared with the 
levels of endogenous proteins by immunoblotting with anti-Xp54 and anti-xRAPB. It was 
found that equivalence for both was reached at between 24 h and 48 h post-injection of the 
relevant vector (Fig. 3B). Interestingly, for both proteins, as the level of tagged protein 
increased, the level of endogenous protein showed a corresponding decline, indicating 
homeostatic regulation. 
    The shorter-term kinetics of co-expression of the recombinant proteins were examined 
by injecting run-off transcripts (using T3 or T7 RNA polymerase) into the cytoplasms of 
mid-stage oocytes and sampling for immunoblotting at two-hourly intervals. As can be 
seen (Fig. 3C), myc-tagged-xRAPB is detected and accumulated from 4 h post-injection.  
However, co-expression with T7-tagged-Xp54 leads to earlier detection of both Xp54 and 
xRAPB (from 2 h). This co-operative effect was then exploited by examining mRNP 
assembly after nuclear co-injection.  
    As with co-precipitation of xRAPB and Xp54 from proteins synthesized in vitro (Fig. 2 
B), immunoprecipitation from lysates of oocytes co-expressing myc-tagged xRAPB and 
T7-tagged Xp54 in vivo, showed co-precipitation using anti-myc epitope, anti-T7 epitope, 
anti-Xp54 or anti-xRAPB (Fig. 3D). Non-immune rabbit serum was used as a negative 
control. The extent of co-precipitation using anti-epitope tags to detect de novo-
synthesized myc-xRAPB and T7-Xp54 corresponded well with co-precipitation results 
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using antibodies directed against the native proteins.  However, antibodies recognizing 
Xp54 were more efficient in co-precipitating xRAPB than were the antibodies recognizing 
xRAPB in co-precipitating Xp54. This would be expected if Xp54 bound to xRAPB 
constitutes only a sub-fraction of the Xp54 population, assuming that the ectopically 
expressed proteins behave in a manner similar to their endogenous equivalents. 
    Stored mRNP particles typically sediment at 30-80S in rate-zonal gradients (Darnbrough 
and Ford, 1981).  In order to check whether xRAPB is actively incorporated in vivo into 
newly-synthesized  particles, epitope-tagged xRAPB and Xp54 were co-expressed in mid-
stage oocytes and their distribution was analysed after sedimentation in glycerol gradients. 
Assembly of newly synthesized xRAPB into mRNP particles was found to correspond (in 
size distribution) to that of newly synthesized Xp54 (Fig. 3E).  Pre-treatment of the oocyte 
extract with ribonuclease resulted in both xRAPB and Xp54 being resolved in smaller 
molecular complexes. In contrast, xRAPA, co-expressed with Xp54, appeared to prevent 
Xp54 from entering into larger mRNP particles, again pointing to the co-operation of 
xRAPB and Xp54, but a dislocation of xRAPA and Xp54, in early mRNP assembly (Fig. 
3F). It should be noted that immunostaining of all three components can be detected in 
pelleted 80S+ material, their continued presence here after ribonuclease treatment (Fig. 
3E,F, bottom panels) probably due to aggregation of released proteins. 
 
3.4 Comparison of the effects of knock-down and over-expression of xRAPA and xRAPB 
    Previous studies have shown that Xenopus xRAPA represses translation in an in vitro 
system and also in vivo in oocytes when tethered to a reporter RNA (Tanaka et al., 2006) 
as has Xp54 (Minshall et al. 2001, 2004). However, injection of anti-xRAPB IgG into 
oocytes does not interfere with the formation of masked reporter transcripts, whereas 
injection of anti-Xp54 IgG releases masked transcripts for translation (Braddock et al. 
1994), indicating that xRAPB may not act as a translation repressor. In order to explore 
this possibility, we compared the effects of knockdown and over-expression of xRAPB, 
xRAPA and Xp54.  
    As expected, injection of anti-sense morpholinos (a/sMOs) into the cytoplasm of 
oocytes expressing recombinant xRAPB and Xp54 from nuclear vectors greatly inhibits 
their synthesis (Fig. 4A), but injection of a/sMOs directed against the endogenous mRNAs 
encoding these protein also results in inhibition (Fig. 4B). No significant MO cross-
reactions were detected in comparing all of the targeted proteins. These findings open the 
possibility of using a/sMOs to examine the effects of depletion of xRAPB, xRAPA and 
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Xp54 on translation rates in injected oocytes. As can be seen (Fig. 4C), Xp54 a/sMO 
significantly increases the rate of protein synthesis, whereas xRAPB a/sMO gives slight 
repression. The effect of xRAPA a/sMO differs little from the effect of a non-specific 
control MO. On comparing the spectrum of labelled proteins by SDS-PAGE / 
autoradiography (Fig.  4D, right panel) it can be seen that the a/sMO treatments result in 
differences of general signal intensity: there is no evidence for an increase or decrease in 
the translation of specific proteins. Also, comparison of the radiolabelling with protein 
staining in individual tracks indicates that the labelled bands do not fully correspond, either 
in intensity or migration to the staining pattern. This reflects oocyte stage-specific 
translation and differental protein stability. Quantitation of track densities are shown in the 
accompanying table, again indicating that the most significant deviation from the control is 
the positive effect of anti-sense of Xp54 mRNA. 
    Results from the reverse experiment, examining the effect of increased expression of 
xRAPB, xRAPA and Xp54 on protein synthesis, are shown (Fig. 4E). Here there is a 
reversal of outcomes, with over-expression of Xp54 resulting in inhibition of protein 
synthesis and over-expression of xRAPB in an apparent activation. xRAPA gave no 
significant difference from the (mock-injected) control. The profiles of newly-synthesized 
proteins (Fig. 4F) again showed differences in overall intensity. In the autoradiograph 
shown, the last two track represents synthesis after co-expression of myc-xRAPB and T7-
Xp54, which can be compared with the expression of these proteins individually. In these 
tracks the over-expressed myc-xRAPB can be discerned at its slower migrating position 
(white dot and upper arrow), whereas over-expressed T7-Xp54 is obscured in the heavier 
labelled region of the gel (white dot and lower arrow).  Quantitation of track densities 
confirm a significant inhibition of translation by over-expressed Xp54 and a modest 
increase in translation of xRAPB (this is with the myc-xRAPB band contribution 
subtracted from the total). Co-expression of xRAPB with Xp54 leads to moderation of the 
repressor activity of Xp54 (Fig. 4F). The least we can conclude is that over-expresion of 
xRAPB does not inhibit the activity of already translating mRNAs. 
 
3.5  xRAPB is associated with translating mRNAs 
        It might be expected that manipulated changes in translation rate would be reflected in 
changes in the distribution of mRNP particles, specifically in association with ribosomal 
components. Rate sedimentation analysis of extracts from mid-stage oocytes containing 
over-expressed Lsm14 proteins show that the distribution of myc-xRAPA remains typical 
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of mRNPs containing endogenous Xp54 and YB2 (Fig. 5A, broken box area), whereas a 
significant proportion of the myc-xRAPB signal has moved into the 80-120S region (solid 
box area) with a much weaker signal in faster sedimenting complexes. The 80-120S 
complexes are disassembled in the presence of EDTA (Fig. 5B) and have previously been 
shown to represent stalled translation initiation complexes (Cummings and Sommerville, 
1988).  
    Whereas mRNP particles from early- to mid-stage oocytes have been described as 
forming a heterogeneous size distribution on rate-sedimentation gradients (Darnbrough and 
Ford, 1981; Cummings and Sommerville, 1988), native xRAPB is seen to be present in 
particles with a bimodal distribution, sedimenting in sub-80S and post-120S fractions. This 
contrasts with Xp54 and YB2, both of which form a continuous distribution across the 80S 
region (Fig. 5C,E, broken box area) and indicates that mRNP particles free of xRAPB are 
also present in mid-stage oocytes. On the other hand, the distribution of xRAPB seen here 
is typical of that of separated stored mRNP and polysomes. Hybridization of gene-specific 
antisense probes with RNA extracted from the gradient fractions confirms that mRNA not 
translated during early oogenesis (eg. encoding cyclin B1, Fig. 5C) is not present in 
putative polysome fractions but, instead, remains in fractions associated with stored 
mRNA. In contrast, early-translated mRNA (eg. encoding -tubulin, Fig. 5C) extends into 
the polysome region, reflecting the bimodal distribution of xRAPB. Support for these 
distributions representing a distinction between mRNP storage and translation complexes 
can be seen from gradients of the same extracts pre-treated with EDTA, which result in the 
total disruption of post-80S RNP with cyclinB1 mRNA now sedimenting with Xp54 and 
YB2 at less than 60S and the -tubulin mRNA sedimenting at less than 40S with xRAPB 
(Fig.5D). The bimodal distribution of xRAPB is better defined in early-stage oocytes (Fig. 
5E), whereas all post-80S signal is absent from ectopically-expressed xRAPB in late-stage 
and matured oocytes (Fig. 5F, broken box area). 
  
3.6 Identification of mRNA classes found in association with xRAPB 
    Confirmation of direct interaction of early-expressed mRNA species with xRAPB is 
obtained from RT-PCR of RNA extracted from immunoprecipitated RNP particles (Fig. 6). 
In order to standardize precipitation and to minimize potential immunological cross-
reaction, both myc-tagged xRAPB and myc-tagged xRAPA were used as the targets for 
monoclonal anti-myc (cf. Huber and Zhao, 2010). As can be seen  (Fig. 6),  
immunoprecipitates (P) from oocytes expressing myc-xRAPB contained mRNA species 
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that are being translated in oocytes (for nuclear actin, -tubulin, EF1a, ribosomal protein 
L14 and HDACm) but not stored mRNAs that are translated later at oocyte maturation (for 
cyclin B1 and c-mos), in the egg (for D7) and during early embryogenesis (for somatic 
YB1 and linker histone H1M). Actively translating mRNAs are not precipitated from 
oocytes expressing myc-xRAPA, whereas stored mRNAs are precipitated to varying 
extent. However, this analysis is complicated by instability of some stored mRNAs (eg. 
encoding cyclin B1 and c-mos), but not of translating mRNAs or embryo-expressed 
mRNAs (eg. for H1M), in myc-xRAPA-expressing oocytes. Additionally, mRNAs that 
pass through localization pathways in early- to mid-stage oocytes (encoding Xcat2 and 
Vg1) but are translationally repressed during oogenesis were also immunoprecipitated 
along with xRAPB. 
     All results shown here were generated from the same cDNA templates, the original 
RNA extracts showing similar amounts of ribosomal RNAs. (Fig. 6.) Furthermore, 
incorporation of ectopically-expressed xRAP proteins is to be expected to be more efficient 
in mRNP complexes with a greater rate of turnover.  
 
4. Discussion  
   Post-transcriptional regulation in the cytoplasm of oocytes falls into several catagories 
including translation activation, distribution of mRNA to specific cellular sites, storage of 
mRNA in a masked form to be activated at the appropriate stage of development and 
degradation/recycling of mRNA to retain a metabolic balance. It is against this background 
that we look for components that determine stage-specific effects, one candidate group 
being the various forms of the Scd6/Lsm14 family which are present in germ cells and 
evolutionarily conserved in eucaryotic somatic cells (Marnef et al., 2009).  
 
4.1 xRAPB as an integral component of poly(A)
+
RNP in early-stage oocytes 
    In this study immunoblots with anti-xRAPB showed that the concentration of xRAPB 
decreases from early oogenesis to full-growth (Fig. 1C,E), a feature confirmed by 
immunostaining ovary sections (Fig. 1D), whereas the concentration of the translation 
repressor xRAPA increases during oogenesis (Tanaka et al., 2006). Cross-reacting 
antibodies clearly show this reciprocal expression pattern (Minshall et al., 2007).  That 
xRAPB co-isolated with Xp54, YB2 and CPEB (Minshall et al., 2007) in association with 
polyadenylated mRNA (Fig. 1E) indicated that this mRNP may be capable of entering the 
translation pathway.  These observations can be compared with the timing of 
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transcriptional activity which starts at maximum in early oocytes and decreases towards 
full growth and with the steady-state level of mRNA that exists from mid to late oogenesis, 
maintaining the pool of stored mRNA required for translation during oocyte maturation 
and early embryogenesis in the absence of further transcription (reviewed, Sommerville, 
1990). Thus the availability of xRAPB matches the timing of early onset events, not only 
mRNA translation for oocyte growth and protein storage but also distribution of mRNA to 
specific cellular sites (Kloc and Etkin, 2005), whereas the availability of xRAPA matches 
the repression and turnover of mRNA and storage of mRNA for later development. 
 
4.2 Interaction of xRAPB with the RNA helicase Xp54  
    The ability of Xp54 and xRAPB to interact with each other: as in vitro-synthesized 
proteins (Fig. 2B); as native proteins in early-stage oocytes (Fig. 2C; Minshall et al., 
2009): as over-expressed proteins in mid-stage oocytes (Fig. 3D), contrasted with a lack of 
comparable interaction of Xp54 with xRAPA. Furthermore, co-expression of Xp54 with 
xRAPB lead to stabilization of xRAPB synthesis (Fig. 3C) and incorporation of both 
proteins into mRNP particles with a heterogeneous range of sizes (Fig. 3E), whereas co-
expression xRAPA with Xp54 leads to the incorporation of xRAPA to the exclusion of 
Xp54, at least in fast-sedimenting particles (Fig. 3F). All of these results confirm 
Xp54/xRAPB selectivity in the assembly of a specific class of mRNP particles during 
early- to mid-oogenesis.     
    It was shown previously that in early oogenesis, YB2a/b are much more stable than 
Xp54 and xRAPB, which have similar turnover rates (Dixon and Ford, 1982). Here, the 
stability of the native Xp54/xRAPB/mRNA complex and removal of YB2a/b in high salt 
conditions (Fig. 1F) is consistent with this functional grouping.  However, activation of 
protein synthesis in early-stage oocytes may require binding of supressor protein or 
conformational change of any Xp54 (Minshall et al., 2009) retained on target mRNAs. The 
modification/stimulus required to suppress Xp54 activity for translation activation is not 
known, although Xp54 phosphorylation (Sommerville, 1990: Weston and Sommerville 
2006) and xRAPB methylation (Matsumoto et al., 2012) can be considered.  
 
 
 
4.3 Involvement of xRAPB in promoting translation  
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    Repression of translation by antisense-morpholinos (a/sMOs) was clearly effective on 
targetted ectopically-expressed mRNA (Fig. 4A), but less so on endogenous mRNA (Fig. 
4B). However, on examining the effects of injecting a/sMOs on in vivo translation, the 
Xp54 MO gave a significantly different effect from the xRAPB MO. As expected of a 
translation repressor, inhibition of Xp54 mRNA gave an ~30% up-regulation, whereas 
inhibition of xRAPB mRNA gave an ~18% down-regulation, indicating, at least, that 
xRAPB is not a translation repressor (Fig. 4C,D). The xRAPA MO showed little difference 
from the control MO, indicating that xRAPA is not involved in on-going translation. The 
profile of labelled bands seen on SDS-PAGE/autoradiography appeared not to change, 
only the overall band intensities (Fig. 4D), indicating that the affected proteins were 
common to the population of translating mRNAs. 
    That some competition for translation components was seen on comparing the levels of 
T7-Xp54 with endogenous Xp54 and of myc-xRAPB with endogenous myc-xRAPB, 
where ectopic expression appeared to increase at some expense to the level of their 
endogenous counterparts (Fig. 3B). Nevertheless, when effects of over-expression of Xp54 
and xRAPB on in vivo translation were examined significant differences were observed in 
the rate of amino acid incorporation (Fig. 4E), especially with T7-Xp54 giving translation 
repression (~ 50%) and myc-xRAPB giving translation stimulation (~ 30%). However, 
even allowing for the contribution of the myc-xRAPB labelled band on autoradiographs, its 
subtraction from the track density still gave ~10% overall stimulation by xRAPB (Fig. 4F, 
table). Again we can claim is that, whereas excess Xp54 clearly functions, as shown earlier 
(Minshall et al., 2001,2004), as a translation repressor, excess xRAPB does not.  
    Rate-sedimentation analysis showed endogenous xRAPB to be present in polysomal 
fractions of extracts taken from early-stage (Fig. 5E) to mid-stage (Fig. 5C) oocytes. The 
bimodal separation of not only xRAPB, but also expressed mRNA (oocyte-specific -
tubulin), and the resolution of both to a single, slow sedimenting mRNP distribution after 
treament of extracts with EDTA confirmed this interpretation (Fig. 5D). Of additional 
interest is that the fractions bridging the bimodal distribution contained high concentrations 
of Xp54 and YB2 but no visible xRAPB (Fig. 5C). These fractions apparently represent an 
alternative class of mRNP, as do fractions that form an intermediate peak containing stored 
mRNA (cyclin B1). 
    In comparison to endogenous activity, myc- over-expressed in mid-stage oocytes 
showed a much weaker signal in the polysome region, but greater than does myc-xRAPA, 
(Fig. 5A). This is to be expected because of the modest (~10%) increase in overall 
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translation seen after over-expression (Fig. 4E,F). Instead, the majority of the myc-xRAPB 
signal was seen in the 80-120 S region of the gradient. That this sedimentation class 
represents the accumulation of stalled translation initiation complexes has been shown 
previously, in extracts from mid-stage oocytes, to contain, in addition to 80 S ribosomes 
and poly(A)
+
RNP particles, charged tRNAmet (Cummings and Sommerville, 1988). 
Furthermore, protein staining showed no obvious loss of xRAPB/Xp54 relative to YB2 in 
the formation of these complexes (Cummings and Sommerville, 1988), their apparent 
under-representation here (Fig. 5A) being due to the stronger myc-epitope signal. Again, 
complex disassembly occurred after EDTA treatment (Fig. 5B). Nevertheless, it must be 
recognized that myc-xRAPB over-expression results in an artificial redistribution of mRNP 
particles (cf. Fig. 5A with C). This effect was over by late oogenesis and maturation, by 
which time no incorporation of myc-xRAPB into stalled initiation complexes was seen 
(Fig. 5F).  
    Retention of xRAPB in stored mRNP particles, stalled initiation complexes and 
polysomes indicates that its removal is not required in progressing through these states of 
activity. A similar situation has already been reported for ovarian tissue of Drosophila, 
where a proportion of the Scd6/Lsm14 protein Tral isolates with polysomes although the 
Xp54 orthologue Me31B isolates only in free mRNP particles (Liu et al., 2011). However, 
in the results presented here, both the masking proteins YB2a/b and the repressor Xp54 
were detected in polysomal regions (Fig. 5C,E) but not after EDTA treatment. In the case 
of YB2, orthologues in mammalian cells (YB1/p50) and Chironomus cells (ctYB1) can 
remain associated with translating mRNAs, albeit with lower stoichiometry (Evdokimova 
and Ovchinikov, 1998; Soop et al., 2003). As already discussed (Section 4.2), any Xp54 
retained may undergo structural modification to release its repression function or be 
sufficiently neutralized by excess or modified xRAPB. 
 
4.4 Identification of mRNAs that bind xRAPB 
    The stability of mRNP complexes incorporating myc-xRAPB has a further use in 
identifying the mRNAs that they contain. That concurrently translated mRNAs are indeed 
associated with xRAPB and not xRAPA was shown by analysis of RT-PCR products of 
RNA co-immunoprecipitated with xRAPB and xRAPA (Fig. 6). All of the sequences 
derived from translating mRNAs were detected in xRAPB co-precipitates and to a much 
lesser extent in xRAPA co-precipitates. Those tested included mRNAs encoding: structual 
proteins (oocyte-specific -tubulin and nuclear actin); translation components (EF1 and 
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ribosomal protein L14) and stored enzymes (maternal histone deacetylase, HDACm). In 
addition, however, a category of mRNAs that are not translated in oocytes was also 
immunoprecipitated along with xRAPB. These are mRNAs localized to the vegetal region 
in early-stage oocytes: encoding Xcat2/Nanos1 (Lai et al., 2011) and in mid-stage oocytes: 
encoding Vg1 (Kloc and Etkin, 2005). The co-precipitation of Vg1 mRNA with xRAPB is 
consistant with the previous demonstration that xRAPB, together with xRAPC (Fig. 1B), 
YB2 and Xp54 can be immunoprecipitated by antibodies recognizing Vg1-localizing 
proteins (Arthur et al., 2009). Here we have shown that early-localized particles containing 
Nanos1 mRNA appear also to contain xRAPB. Since Nanos mRNA is specifically 
translated in the next generation of precursor germ cells, perhaps xRAPB, if still bound, is 
required for its early activation. 
    Of the mRNAs not co-precipitated with xRAPB (Fig. 6), co-precipitation with xRAPA 
was also absent from those mRNAs not translated until egg formation (D7) or early 
embryogenesis (somatic YB1 and maternal linker histone H1M). Although the mRNAs to 
be translated during oocyte maturation (cyclinB1 and c-mos) did appear to have bound 
xRAPA, the mRNAs themselves appear to be unstable. This may well be due to the over-
expression of xRAPA, known to be a component involved with Xp54 in the RNA 
degradation pathway. This highlights a potential limitation of the use of epitope-tagged 
proteins as a target for immunoprecipitation: although they present optimum antigenicity, 
their over-expression may lead to metabolic side-effects. 
 
4. 5 Additional functions of Scd6/Lsm14 proteins 
    Induction of mRNA degradation by over-expressed Scd6/Lsm14 has been well 
documented for a wide range of organisms (Marnef et al., 2009; Balagopal and Parker, 
2009) and in vertebrates appears to be essential for the formation of P-bodies. Xenopus 
xRAPA has been shown to be present in non-defined cytoplasmic foci in oocytes and to 
locate to P-bodies when expressed in mammalian cells (Tanaka et al., 2006). Furthermore, 
tethering of xRAPA to a reporter mRNA expressed in late-stage oocytes caused a decrease 
in the levels of the reporter protein. However, early growth of mouse oocytes is 
accompanied by the loss of P-bodies and, as with Xenopus Vg1 and Nanos1, translocation 
of mRNP complexes (lacking decapping enzymes) to sub-cortical regions (Flemr et al., 
2010) and translationally silent mRNAs in the gametocytes of Plasmodium are contained 
in storage granules defined by the presence of the p54/DDX6 and Scd6/Lsm14 
orthologues, DOZ1 and CITH, but the absence of RNA degradation factors (Mair et al., 
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2010). Thus germ cells may present a special case in the use of p54/DDX6 and 
Scd6/Lsm14 for mRNA storage and distribution rather than degradation. 
 
Conclusions 
    The major feature of Scd6/Lsm14 proteins in oogenic/embryonic systems lies in their 
efficient handling of mRNA through the developmental programme. In Xenopus oocytes, 
at least, this is managed through the involvement of different Lsm14 proteins: xRAPA and 
xRAPB and possibly others. As argued here, xRAPB is responsible for the selective 
translation or distribution, from the total pool, of those mRNAs required for oocyte growth 
and development,  whereas xRAPA is required for translation repression, mRNA 
degradation and storage of those mRNAs required for late oogenesis and meiosis. Since 
RAPB paralogues might be critical for oogenesis and fertility, their study in other 
eukaryotes should be well worthwhile. 
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Figure legends 
Fig. 1. Identification and expression of xRAPB (A) Immunoblot of poly(A)
+
RNP fractions 
from oocytes of Xenopus laevis and Pleurodeles waltl  reacted with guinea pig anti-RAP55 
and rabbit anti-Xp52. (B) Alternative designations of the three Xenopus Scd6 proteins 
described to date (left panel) and their percentage identities (right panel). (C) Comparison 
of expression through oocyte stages of Xp52/xRAPB and the RT-PCR products of the 
mRNA encoding xRAPB. (D) Immunostaining of ovary section with anti-xRAPB showing 
reaction with stages I – IV. Perimeters of the stage III and IV oocytes are indicated by 
white outlines. Bar indicates 200 m. (E) Immunoblot of extracts from early-stage oocytes 
and progesterone matured oocytes, unbound (UB) and bound (B) by oligo(dT)- (cellulose. 
Lysates were obtained in the presence of 2mM Mg2Cl or 5 mM EDTA. The transfer was 
reacted serially with anti-xRAPB; anti-Xp54; anti-YB2; anti-CPEB; anti-ERK2 and anti-
phosphorylated MAPkinase (pMAPK). (F) Immunoblot of Cs2SO4 density gradient 
fractions of poly(A)
+
 RNP reacted with antibodies reacting with YB2, Xp54 and xRAPB. 
An immunoblot of the poly(A)
+
 RNP peak fraction taken from a CsCl density gradient, 
reacted with the same antibodies, is shown for comparison (right panel). Slot blots of RNA 
extracted from the same fractions from parallel gradients (lower panels) were reacted with 
32
P-labelled antisense probes recognizing the mRNAs of nucleolin and histone deacetylase 
(HDAC). 
 
Fig. 2. Interactions of xRAPB and xRAPA with Xp54. (A) Autoradiograph of an SDS-
PAGE gel showing the 
35
S-labelled recombinant proteins synthesized and labelled by 
coupled transcription/translation using cloned cDNAs in a reticulocyte lysate system. (B) 
Immunoprecipitations of 
35
S-labelled xRAPB/Xp54 and xRAPA/Xp54 mixes with 
immobilized anti-Xp54 and anti-xRAPB. Bound (B) and unbound (UB) fractions. (C) 
Immunostained transfers from SDS-PAGE gels of oocyte poly(A)
+
 RNP, untreated and 
u.v.-cross-linked (UV) and with subsequent digestion with ribonuclease A (RNase). 
Putative, cross-linked Xp54/xRAPB heterodimers (~110 kDa) are recognized by anti-Xp54 
and anti-xRAPB. Material recovered as a pellet from heat-treated poly(A)
+
 RNP (HTP) 
was raised in 8M urea and renatured by serial dilution into HB prior to crosslinking. The 
gel transfer, reacted with both antibodies together, shows a single discrete RNase-resistant 
band at ~110 kDa. The two other major mRNP proteins, YB2a/b, are not detected in cross-
linked complexes with this same mobility. RNA/protein complexes resolved by RNase 
treatment are indicated (arrows). 
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Fig. 3. Complementation of xRAPB and Xp54 in the formation of mRNP particles.  
(A) Recombinant proteins produced from expression vectors used in this study. (B) 
Comparison of the rates of production of the epitope-tagged proteins, T7-Xp54 and myc-
xRAPB, after injection of the vectors into the nuclei of mid-stage oocytes, with the levels 
of endogenous proteins (endo-Xp54 and endo-xRAPB).  (C) Time course of translation in 
vivo from RNA transcripts encoding myc-tagged xRAPB, with and without co-translation 
of Xp54. The RNA was injected into the cytoplasms of mid-stage oocytes. (D) 
Immunoprecipitation from lysates of oocytes co-expressing myc-xRAPB and T7-Xp54. 
Expression vectors encoding the epitope-tagged proteins were injected into the nuclei of 
mid-stage oocytes, which were incubated for 36 h before extraction. Proteins were 
unbound (UB) or bound (B) to immobilized anti-myc, anti-T7, anti-xRAPB, anti-Xp54 or 
non-immune serum (NI) and separated by SDS-PAGE. The transfer was reacted serially 
with anti-myc and anti-T7. Note that in the second lane of the anti-T7 panel the protein has 
mainly tracked to the edges. (E and F) Sedimentation analysis of mRNP particles formed 
during the co-expression of myc-xRAPB and T7-Xp54 and myc-xRAPA and T7-Xp54. 
Glycerol gradient fractions were separated by SDS-PAGE and immunoblotted using first 
anti-myc, then anti-T7. Equal volumes of extracts were pre-treated with ribonuclease A 
(+RNase) prior to sedimentation. Ribosomal monomers sediment to the bottom of the 
centrifuge tubes, the pellet also containing larger complexes (80S+). 
 
Fig. 4. Effects of knock-down and over-expression of xRAPA and xRAPB on translation 
rate. (A) Effect of antisense morpholinos (a/s MOs) recognizing tagged epitope sequences 
on co-expressed myc-xRAPB and T7-Xp54. Vector injections as for Fig. 3C with MO 
injections after 12 h. (B) Effect of a/sMOs recognizing the translation start sites of 
endogenous xRAPB and Xp54 at 24 and 48h after cytoplasmic injection into mid-stage 
oocytes. Control is a random sequence MO. (C) Effect of a/sMOs recognizing xRAPA (A), 
xRAPB (B) and Xp54 (P) on the rate of amino acid incorporation compared with control 
MO (C). Oocytes injected with MOs were incubated for 12 h before addition of [
35
S]-
methionine to the medium. Oocytes from each set were recovered at hourly intervals and 
processed to obtain percentage of radioactivity incorporated into protein. Data from three 
separate experiments were used to obtain means and standard deviations. (D) 
Autoradiographs of SDS-PAGE separated proteins were also obtained. A stained gel track 
(St) is shown to represent the total protein profile. Track density measurements taken from 
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autoradiographs representing four separate experiments were analysed and shown in the 
table (right). Numbers represent means and standard deviations. (E) As for (C) but with 
injection of expression vectors replacing MO injection. (F) As for (D) but showing results 
from over-expression of Xp54 (P) and xRAPB (B), and also from co-expression of Xp54 
and xRAPB (PB). Bands attributed to the ectopically-expressed proteins (white spots and 
arrows) were subtracted from measurement of intensity totals. Numbers in the table (right) 
represent data from three separate experiments. 
 
Fig. 5. Comparison in size distribution of mRNP particles containing xRAPA and xRAPB. 
(A) Sedimentation analysis of mRNP particles in extracts from mid-stage oocytes 
expressing either myc-xRAPA (upper panels) or myc-xRAPB (lower panels). Gradient 
fractions were separated by SDS-PAGE and immunoblotted with anti-myc, anti-Xp54 and 
anti-YB2 comparing the fastest sedimenting mRNP fractions containing myc-xRAPA 
(broken box) with those containing myc-xRAPB (solid box). (B) As (A) but with 5mM 
EDTA replacing 2 mM Mg
2+
. Peak sedimentation of ribosomal monomers (80S) and sub-
units (60S and 40S) are indicated as rate markers. (C) Sedimentation analysis of mRNP 
particles in extracts from mid-stage oocytes expressing only endogenous proteins. Gradient 
fractions separated by SDS-PAGE and immunoblotted with anti-xRAPB, anti-Xp54 and 
anti-YB2. Fractions of mRNP lacking xRAPB are highlighted (broken box). RNA 
extracted from aliquots of each of the gradient fractions was applied to a membrane by 
slot-blotting, the blot subsequently being hybridized with radiolabelled probes, antisense to 
mRNA encoding oocyte-specific -tubulin and cyclin B1. Autoradiographs of the blots are 
shown (bottom panels). (D) As (C) but with 5mM EDTA replacing 2 mM MgCl2. (E) As 
(C) except extract from early-stage oocytes. (F) As (A) except with extract from maturing 
oocytes (6 h after progesterone) expressing myc-xRAPB but showing a lack of xRAPB in 
post-80S  fractions (broken box).  
 
Fig. 6. Analysis of mRNAs immunoprecipitated (IP) by anti-myc from extracts from 
oocytes expressing myc-xRAPA or myc-xRAPB. RNA extracted from unbound (UB) and 
bound (B) fractions was used as templates for RT-PCR amplification using gene-specific 
primers for oocyte-specific genes.  Represented here are: (a) mRNAs that are expressed as 
protein starting from early oogenesis: structural proteins, -tubulin and nuclear actin (N-
actin); translation components, eIF1 and ribosomal protein L14; and stored enzymes, 
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histone deacetylase (HDACm); (b) stored mRNAs specifically directed to subcellular 
compartments, Xcat2/Nanos1 and Vg1; (c) stored mRNAs encoding proteins required for 
oocyte maturation, cyclin B1 and c-mos; (d) stored mRNA translated in eggs, D7; (e) 
stored mRNAs translated during early embryogenesis, mRNP protein YB1 and linker 
histone H1M. Products are separated on 1.5% agarose gels. Ribosomal RNAs (28S+18S 
and 5S) isolated from the same IP fractions are also shown (bottom panels). 
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Highlights 
 
 The Scd6/Lsm14b protein xRAPB is expressed during early oogenesis in Xenopus. 
 xRAPB interacts with the DDX6 helicase Xp54 in poly(A)
+
mRNP particles. 
 xRAPB-associated mRNAs are predisposed for translation or intra-cell 
translocation. 
